share_log

Piper Sandler Maintains Overweight on Fulcrum Therapeutics, Raises Price Target to $15

Moomoo 24/7 ·  Feb 28 10:44

Piper Sandler analyst Edward Tenthoff maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Overweight and raises the price target from $13 to $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment